Evidence for the presence of CB 2 -like cannabinoid receptors on peripheral nerve terminals

Author： Griffin G.   Fernando S.R.   Ross R.A.   McKay N.G.   Ashford M.L.J.   Shire D.   Huffman J.W.   Yu S.   Lainton J.A.H.   Pertwee R.G.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.339, Iss.1, 1997-11, pp. : 53-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Further evidence for the presence of cannabinoid CB 1 receptors in mouse vas deferens

By Pertwee R.G.   Joe-Adigwe G.   Hawksworth G.M.  

European Journal of Pharmacology, Vol. 296, Iss. 2, 1996-01 ,pp. : 169-172

Elsevier

Access to resources Recommend Favorite

Cannabinoid CB2 Receptors in Health and Disease

By  

Current Medicinal Chemistry, Vol. 17, Iss. 14, 2010-05 ,pp. : 1394-1410

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands

By  

Current Medicinal Chemistry, Vol. 21, Iss. 2, 2014-01 ,pp. : 187-203

Bentham Science Publishers

Access to resources Recommend Favorite

Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS

By  

Current Neuropharmacology, Vol. 9, Iss. 1, 2011-03 ,pp. : 205-208

Bentham Science Publishers

Access to resources Recommend Favorite

Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB 1 /CB 2 receptors

By Brooks J.W.   Pryce G.   Bisogno T.   Jaggar S.I.   Hankey D.J.R.   Brown P.   Bridges D.   Ledent C.   Bifulco M.   Rice A.S.C.   Di Marzo V.   Baker D.  

European Journal of Pharmacology, Vol. 439, Iss. 1, 2002-03 ,pp. : 83-92

Elsevier

Access to resources Recommend Favorite